Department of Medicine, Section of General Internal Medicine, Boston University School of Medicine and Boston Medical Center, Boston, MA, USA.
Grayken Center for Addiction, Boston Medical Center, Boston, MA, USA.
Addict Sci Clin Pract. 2021 Dec 28;16(1):73. doi: 10.1186/s13722-021-00279-x.
In the United States, methadone for opioid use disorder (OUD) is limited to highly regulated opioid treatment programs (OTPs), rendering it inaccessible to many patients. The "72-hour rule" allows non-OTP providers to administer methadone for emergency opioid withdrawal management while arranging ongoing care. Low-barrier substance use disorder (SUD) bridge clinics provide rapid access to buprenorphine but offer an opportunity to treat acute opioid withdrawal while facilitating OTP linkage. We describe the case of a patient with OUD who received methadone for opioid withdrawal in a bridge clinic and linked to an OTP within 72 h.
A 54-year-old woman with severe OUD was seen in a SUD bridge clinic requesting OTP linkage and assessed with a clinical opiate withdrawal scale (COWS) score of 12. She reported daily nasal use of 1 g heroin/fentanyl. Prior OUD treatment included buprenorphine-naloxone, which was only partially effective. Her acute opioid withdrawal was treated with a single observed oral dose of methadone 20 mg. She returned the following day with persistent opioid withdrawal (COWS score 11) and was treated with methadone 40 mg. On day 3, the patient was successfully admitted to a local OTP, where she remained engaged 3 months later.
While patients continue to face substantial access barriers, bridge clinics can play an important role in treating opioid withdrawal, building partnerships with OTPs to initiate methadone on demand, and preventing life-threatening delays to methadone treatment. Federal policy reform is urgently needed to make methadone more accessible to people with OUD.
在美国,美沙酮治疗阿片类药物使用障碍(OUD)仅限于高度监管的阿片类药物治疗计划(OTP),使得许多患者无法获得美沙酮。“72 小时规则”允许非 OTP 提供者在安排持续护理的同时,管理紧急阿片类药物戒断管理中使用美沙酮。低门槛物质使用障碍(SUD)桥接诊所提供了快速获得丁丙诺啡的途径,但也提供了治疗急性阿片类药物戒断的机会,同时促进了 OTP 链接。我们描述了一名 OUD 患者在桥接诊所接受美沙酮治疗阿片类药物戒断并在 72 小时内与 OTP 联系的病例。
一名 54 岁女性,患有严重的 OUD,在 SUD 桥接诊所就诊,要求链接 OTP,并接受临床阿片类戒断量表(COWS)评分 12。她报告每天使用 1 克海洛因/芬太尼经鼻使用。先前的 OUD 治疗包括丁丙诺啡-纳洛酮,仅部分有效。她的急性阿片类药物戒断用单次口服美沙酮 20 毫克治疗。第二天,她因持续的阿片类药物戒断(COWS 评分 11)返回,并接受美沙酮 40 毫克治疗。第三天,患者成功入院当地 OTP,3 个月后仍保持参与。
尽管患者继续面临实质性的获得障碍,但桥接诊所可以在治疗阿片类药物戒断方面发挥重要作用,与 OTP 建立合作伙伴关系,按需启动美沙酮治疗,并防止美沙酮治疗的致命延误。迫切需要联邦政策改革,使美沙酮更容易获得 OUD 患者。